| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |